Early Exclusive Enteral Nutrition in Early Preterm Infants

Last updated: April 19, 2024
Sponsor: Belal Alshaikh
Overall Status: Completed

Phase

N/A

Condition

Diet And Nutrition

Treatment

Early exclusive enteral nutrition

Clinical Study ID

NCT03708068
REB18-0772
  • Ages < 48
  • All Genders

Study Summary

Enteral nutrition in preterm infants is usually started and advanced slowly until reaching full enteral feeds. Most preterm infants born before 34 weeks gestation require parenteral fluids to maintain normal blood sugar level and prevent excessive weight loss and dehydration. Availability of donor human milk (DHM) along with low incidence of necrotizing enterocolitis (NEC) in preterm infants born at 30-33 weeks have encouraged neonatologists to start feeding early and advance it faster in order to shorten time on parenteral nutrition (PN) and minimize the need for intravenous access. The objectives of this trial is to study whether exclusive enteral nutrition from day of birth (i.e. no PN) results in shorter time to achieve full enteral feed when compared with traditional feeding regimen that involves a combination of PN and progressive enteral feeding.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Preterm infants born at 30 0/7 - 33 6/7 weeks gestation
  2. Birth weight greater than 1000 g
  3. Consent to use donor human milk
  4. Postnatal age is less than 48 hours from birth
  5. Infant is ready to start on feeding (as per clinical team) or feeding volume, whenalready started, is ≤12 ml/kg per day (total) and/or the infant received ≤2 feedsbased on current feeding policy or physician descrition (total volume of the receivedfeeds is ≤20 ml/kg per day).

Exclusion

Exclusion Criteria:

  1. Cord PH < 7.00 or Cord base access (BE) < -16
  2. Apgar score < 7 at 5 minute
  3. Lactate level ≥3 (if done for clinical indication)
  4. Need for positive pressure ventilation (PPV) for >1 minute.
  5. Hemodynamic instability (hypotension or poor perfusion at any time in this 48 hours)
  6. Small for gestational age <3 percentile on Fenton chart and/or fetal absent orreversed umbilical arterial end-diastolic blood flow.
  7. Major congenital malformation
  8. Symptomatic or severe hypoglycemia (blood glucose <1.8 mmol/L)
  9. Infants with moderate to severe respiratory distress.

Study Design

Total Participants: 69
Treatment Group(s): 1
Primary Treatment: Early exclusive enteral nutrition
Phase:
Study Start date:
April 16, 2019
Estimated Completion Date:
January 30, 2024

Study Description

Early nutritional support of preterm infants born at 30-33 weeks gestation is usually achieved via a combination of parenteral nutrition (PN) and enteral feeding that is advanced over few days to reach full enteral feed. Recent studies suggest that rapid increase of enteral feed volumes results in shorter duration on PN and earlier achievement of full enteral feed without increasing the risk of necrotizing enterocolitis (NEC) or death. Although PN has an important role in nutrition of preterm infants, it is associated with increased risk of metabolic and infectious complications even when it is used for a short period of time. Furthermore, PN mandates the need for peripheral or central intravenous access. Provision of full enteral feed volume that meets reference daily fluid intake from day of birth is used frequently and successfully in stable preterm infants born after 33 weeks. Expanding the use of this regimen to stable preterm infants born at 30-33 weeks gestation may help avoid unnecessary start of intravenous access, prevent complications related to PN, and encourage mother-infant bonding experience.

Connect with a study center

  • Foothills Medical Centre

    Calgary, Alberta T2N2T9
    Canada

    Site Not Available

  • Peter Lougheed Hospital

    Calgary, Alberta T1Y6J4
    Canada

    Site Not Available

  • South Health Campus

    Calgary, Alberta T3M1P9
    Canada

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.